GYS1 and glioblastoma: GYS1 is one of the main regulators of glycogen synthesis, and GYS1 inhibition causes glycogen accumulation in glioblastoma cells, leading to proliferation and migration suppression and formation of ROS, indicating GYS1 inhibition may be a promising therapeutic target for glioma24,25.